Quantitative imaging of estrogen receptor expression in breast cancer with PET and 18F-fluoroestradiol

LM Peterson, DA Mankoff, T Lawton… - Journal of Nuclear …, 2008 - Soc Nuclear Med
The PET compound 18F-fluoroestradiol (18F-FES) has been developed and tested as an
agent for the imaging of estrogen receptor (ER) expression in vivo. 18F-FES uptake has …

Quantitative Imaging of Estrogen Receptor Expression in Breast Cancer with PET and^ sup 18^ F-Fluoroestradiol

LM Peterson, DA Mankoff, T Lawton… - The Journal of …, 2008 - search.proquest.com
The PET compound^ sup 18^ F-fluoroestradiol (^ sup 18^ F-FES) has been developed and
tested as an agent for the imaging of estrogen receptor (ER) expression in vivo.^ sup 18^ F …

Quantitative imaging of estrogen receptor expression in breast cancer with PET and 18F-fluoroestradiol

LM Peterson, DA Mankoff, T Lawton… - Journal of Nuclear …, 2008 - ohsu.elsevierpure.com
The PET compound 18 F-fluoroestradiol (18 F-FES) has been developed and tested as an
agent for the imaging of estrogen receptor (ER) expression in vivo. 18 F-FES uptake has …

[PDF][PDF] Quantitative Imaging of Estrogen Receptor Expression in Breast Cancer with PET and 18F-Fluoroestradiol

LM Peterson, DA Mankoff, T Lawton, K Yagle… - J Nucl Med, 2008 - Citeseer
The PET compound 18F-fluoroestradiol (18F-FES) has been developed and tested as an
agent for the imaging of estrogen receptor (ER) expression in vivo. 18F-FES uptake has …

[PDF][PDF] Quantitative Imaging of Estrogen Receptor Expression in Breast Cancer with PET and 18F-Fluoroestradiol

LM Peterson, DA Mankoff, T Lawton, K Yagle… - J Nucl …, 2008 - Soc Nuclear Med
The PET compound 18F-fluoroestradiol (18F-FES) has been developed and tested as an
agent for the imaging of estrogen receptor (ER) expression in vivo. 18F-FES uptake has …

[PDF][PDF] Quantitative Imaging of Estrogen Receptor Expression in Breast Cancer with PET and 18F-Fluoroestradiol

LM Peterson, DA Mankoff, T Lawton, K Yagle… - J Nucl …, 2008 - researchgate.net
The PET compound 18F-fluoroestradiol (18F-FES) has been developed and tested as an
agent for the imaging of estrogen receptor (ER) expression in vivo. 18F-FES uptake has …

Quantitative imaging of estrogen receptor expression in breast cancer with PET and 18F-fluoroestradiol

LM Peterson, DA Mankoff, T Lawton… - Journal of nuclear …, 2008 - pubmed.ncbi.nlm.nih.gov
The PET compound (18) F-fluoroestradiol ((18) F-FES) has been developed and tested as
an agent for the imaging of estrogen receptor (ER) expression in vivo.(18) F-FES uptake has …

Quantitative imaging of estrogen receptor expression in breast cancer with PET and 18F-fluoroestradiol.

LM Peterson, DA Mankoff, T Lawton… - Journal of Nuclear …, 2008 - europepmc.org
Methods Seventeen patients with primary or metastatic breast cancer were studied with
dynamic (18) F-FES PET; cancer tissue samples, collected close to the time of imaging, were …

[PDF][PDF] Quantitative Imaging of Estrogen Receptor Expression in Breast Cancer with PET and 18F-Fluoroestradiol

LM Peterson, DA Mankoff, T Lawton, K Yagle… - J Nucl …, 2008 - scholar.archive.org
The PET compound 18F-fluoroestradiol (18F-FES) has been developed and tested as an
agent for the imaging of estrogen receptor (ER) expression in vivo. 18F-FES uptake has …